Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SKYE US Equity

Skye Bioscience, Inc.Health Care · Pharmaceutical Preparations · CIK 1516551 · FY ends Dec 31
$0.31
-0.05 (-14.79%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 1 13D · 0 13G
DateEventWhat happened / filerSource
2026-08-1813D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by 5AM Partners VII, LLCsec.gov ↗
2026-08-188-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-08-148-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-148-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-08-148-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-148-K 5.01Changes in control of registrantsec.gov ↗
2026-08-148-K 3.03Material modification to rights of security holderssec.gov ↗
2026-08-148-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-148-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-14

Every row is a filed document, checked against its EDGAR index.